Inactive Instrument

Bonus BioGroup Ltd. TEL AVIV STOCK EXCHANGE

BONS

IL0004850116

Biotechnology & Medical Research

Bonus BioGroup Ltd. announced that it has received ILS 1.2 million in funding

June 14, 2015

On June 15, 2015, Bonus BioGroup Ltd. (TASE:BONS) closed the transaction.

Latest news about Bonus BioGroup Ltd.

Bonus BioGroup Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
Bonus BioGroup Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-30	CI
Bonus BioGroup Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31/08/23	CI
Bonus BioGroup Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	29/05/23	CI
Bonus BioGroup Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	30/11/22	CI
Bonus Biogroup Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	31/05/21	CI
Bonus BioGroup Ltd. announced that it expects to receive ILS 9 million in funding	10/04/17	CI
Bonus BioGroup Ltd. Auditor Raises 'Going Concern' Doubt	30/03/17	CI
Bonus BioGroup Ltd. announced that it has received ILS 8 million in funding	27/11/16	CI
Bonus BioGroup Ltd. announced that it expects to receive $1.46 million in funding	24/11/16	CI
Bonus BioGroup Ltd. announced that it expects to receive ILS 8 million in funding	04/10/16	CI
Bonus BioGroup Ltd. announced that it expects to receive ILS 4 million in funding	09/07/16	CI

Bonus Biogroup Ltd, formerly Oceana Advanced Industries Ltd, is an Israel-based product-focused biotechnology company applying technology for supplying bone regeneration tissues. The Company is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. It is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.

Sector

Biotechnology & Medical Research

More about the company